Atlas Trials

Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.

Clinical trial NCT07717268 · RECRUITING

Trial details

NCT number
NCT07717268
Sponsor
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostatic Neoplasms, Castration-Resistant
Start date
2024-05-16
Primary completion
2030-05-16
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.